[1
]
EurOPDX Consortium and are at the Royal College of Surgeons in Ireland, Dublin 2,
Ireland.
[2
]
EurOPDX Consortium and are at the Breast Cancer Now Research Unit, Division of Molecular
and Clinical Cancer Sciences, Manchester Cancer Research Centre, University of Manchester,
Manchester M20 4QL, UK.
[3
]
EurOPDX Consortium and are at the Katholieke Universiteit Leuven, 3000 Leuven, Belgium.
[4
]
The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.
[5
]
EurOPDX Consortium and are at the Vall d'Hebron Institute of Oncology, 08035 Barcelona,
the Universitat Autònoma de Barcelona, 08193 Bellaterra, and the Institució Catalana
de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.
[6
]
CIBERONC, 08035 Barcelona, Spain.
[7
]
EurOPDX Consortium and are at the Wolfson Wohl Cancer Research Centre, Institute of
Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.
[8
]
EurOPDX Consortium and are at Cancer Research UK Cambridge Institute, Cambridge Cancer
Centre, University of Cambridge, Cambridge CB2 0RE, UK.
[9
]
EurOPDX Consortium and is at the Institute of Biostatistics and Analyses, Faculty
of Medicine, and Research Centre for Toxic Compounds in the Environment, Faculty of
Science, Masarykova Univerzita, 625 00 Brno, Czech Republic.
[10
]
Hubrecht Institute, University Medical Centre Utrecht, and Princess Maxima Center
for Pediatric Oncology, 3584CT Utrecht, The Netherlands.
[11
]
EurOPDX Consortium and are at Lausanne Branch, Ludwig Institute for Cancer Research
at the University of Lausanne, 1066 Lausanne, Switzerland.
[12
]
EurOPDX Consortium and is at the Institut Curie, PSL Research University, Translational
Research Department, 75005 Paris, and Université Paris Descartes, Sorbonne Paris Cité,
Faculté de Pharmacie de Paris, 75006 Paris, France.
[13
]
University of Colorado Cancer Center, Aurora, Colorado 80045, USA.
[14
]
EurOPDX Consortium and is at the Cancer Epigenetics and Biology Program, Bellvitge
Biomedical Research Institute IDIBELL, 08908 L'Hospitalet de Llobregat, Barcelona,
Spain.
[15
]
EurOPDX Consortium and is at Beth Israel Deaconess Medical Center, Boston, Harvard
Medical School, Boston, Massachusetts 02215, USA.
[16
]
EurOPDX Consortium and is at the University Medical Centre Groningen, University of
Groningen, 9713GZ Groningen, The Netherlands.
[17
]
EurOPDX Consortium and are at The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX
Amsterdam, The Netherlands.
[18
]
EurOPDX Consortium and are at the Department of Experimental Oncology, European Institiute
of Oncology, 20139 Milan, Italy.
[19
]
EurOPDX Consortium and are at Oslo University Hospital, Institute for Cancer Research,
0424 Oslo, Norway.
[20
]
EurOPDX Consortium and are at Institut Curie, PSL Research University, Translational
Research Department, 75005 Paris, France.
[21
]
EurOPDX Consortium and is at the Laboratory for Molecular Cancer Biology, Department
of Oncology, Katholieke Universiteit Leuven, and the Center for Cancer Biology, VIB,
3000 Leuven, Belgium.
[22
]
EurOPDX Consortium and are at the Candiolo Cancer Institute IRCCS and Department of
Oncology, University of Torino, 10060 Candiolo, Torino, Italy.
[23
]
EurOPDX Consortium and are at the Vall d'Hebron Institute of Oncology and CIBERONC,
08035 Barcelona, Spain.
[24
]
EurOPDX Consortium and is at the Program Against Cancer Therapeutic Resistance (ProCURE),
Catalan Institute of Oncology ICO, Bellvitge Biomedical Research Institute IDIBELL,
08098 L'Hospitalet de Llobregat, Barcelona, and Xenopat S.L., Business Bioincubator,
Bellvitge Health Science Campus, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
[25
]
Seeding Science SAS, 75020 Paris, France.